ADAMIS PHARMACEUTICALS CORPORATION

(ADMP)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
0.3749 USD   +0.24%
07:31aAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update
AQ
08/01ADAMIS PHARMACEUTICALS : Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19 - Form 8-K
PU
08/01ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ADAMIS PHARMACEUTICALS CORPORATION
07:31aAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01ADAMIS PHARMACEUTICALS : Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
07/29THE DEADLINE FOR STOCKHOLDERS TO VOT : 59 p.m. PT on August 11, 2022 - Form 8-K
PU
07/29Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals' Stockhol..
AQ
07/29Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
07/29Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
07/21Adamis Pharmaceuticals Issues Letter to Stockholders
AQ
07/05Adamis Pharmaceuticals Corporation announced that it has received $0.3 million in fundi..
CI
06/01Adamis Pharmaceuticals Receives Data Safety Monitoring Board's Recommendation to Contin..
MT
06/01Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
06/01Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
05/26Adamis Appoints Vickie Reed to Board of Directors
AQ
05/26Adamis Pharmaceuticals Corporation Appoints Vickie Reed to Board of Directors
CI
More most relevant news
All news about ADAMIS PHARMACEUTICALS CORPORATION
07:31aAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01ADAMIS PHARMACEUTICALS : Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
08/01Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
07/29THE DEADLINE FOR STOCKHOLDERS TO VOT : 59 p.m. PT on August 11, 2022 - Form 8-K
PU
07/29ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
07/29Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals' Stockhol..
AQ
07/29Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
07/29Adamis Pharmaceuticals Corporation Provides Update on Clinical Study Assessing Tempol f..
CI
More news
News in other languages on ADAMIS PHARMACEUTICALS CORPORATION
07/29Adamis Pharmaceuticals Corporation fait le point sur l'étude clinique évaluant Tempol p..
06/01Adamis Pharmaceuticals reçoit la recommandation du Data Safety Monitoring Board de pour..
06/01Adamis Pharmaceuticals Corporation fait le point sur l'étude clinique évaluant le Tempo..
05/26Adamis Pharmaceuticals Corporation nomme Vickie Reed au conseil d'administration
05/18Adamis Pharmaceuticals nomme David Marguglio, Chief Business Officer, au poste de PDG
05/18Adamis Pharmaceuticals annonce une transition de direction pour soutenir une nouvelle p..
05/18Adamis Pharmaceuticals annonce des changements dans sa direction
05/16Adamis Pharmaceuticals réduit sa perte nette au 1er trimestre ; le revenu diminue
05/16Adamis Pharmaceuticals Corporation annonce ses résultats pour le premier trimestre clos..
03/31Adamis Pharmaceuticals Corporation annonce ses résultats pour l'exercice complet clos l..
More news
Press releases
07:31aAdamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call ..
AQ
08/01ADAMIS PHARMACEUTICALS : Provides Update on Clinical Study Assessing Tempol for the Treatm..
PU
08/01ADAMIS PHARMACEUTICALS CORP : Other Events (form 8-K)
AQ
08/01Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treat..
AQ
08/01Adamis Pharmaceuticals Corporation - Leading Independent Proxy Advisory Firm ISS Recomm..
AQ
More press releases
Upcoming event on ADAMIS PHARMACEUTICALS CORPORATION